ENDOLA : A GINECO-GINEGEPS French NCI sponsored phase I/II trial to assess the safety and efficacy of metronomic cyclophosphamide, metformin and OLAparib in recurrent advanced/metastatic ENDometrial cancer patients
You, B., Dugue, A., Leary, A., Rodrigues, M., Follana, P., Maucort-Boulch, D., Verane, S., Tod, M., Freyer, G.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article